These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30963332)

  • 21. Extended-release ranolazine: critical evaluation of its use in stable angina.
    Truffa AA; Newby LK; Melloni C
    Vasc Health Risk Manag; 2011; 7():535-9. PubMed ID: 21915171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
    Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
    Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina.
    Tamargo J; Lopez-Sendon J
    Future Cardiol; 2022 Mar; 18(3):235-251. PubMed ID: 34841884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
    Rosano GMC; Vitale C; Volterrani M
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.
    Ahmed B; Mondragon J; Sheldon M; Clegg S
    Cardiovasc Revasc Med; 2017 Sep; 18(6):431-435. PubMed ID: 28576663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
    Nguyen E; Coleman CI; Kohn CG; Weeda ER
    Int J Cardiol; 2018 Dec; 273():34-38. PubMed ID: 30266352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial.
    Mehta PK; Sharma S; Minissian M; Harsch MR; Martinson M; Nyman JA; Shaw LJ; Bairey Merz CN; Wenger NK
    J Womens Health (Larchmt); 2019 May; 28(5):573-582. PubMed ID: 30888919
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostics, therapy and the importance of quality of life in patients with chronic coronary syndrome. Results oft the general practitioner care study ALTHEA].
    Dechend R
    MMW Fortschr Med; 2022 Apr; 164(Suppl 6):11-17. PubMed ID: 35449487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris.
    Vellopoulou K; Kourlaba G; Maniadakis N; Vardas P
    Int J Cardiol; 2016 May; 211():105-11. PubMed ID: 26994453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Argirò A; Zampieri M; Dei LL; Ferrantini C; Marchi A; Tomberli A; Baldini K; Cappelli F; Favilli S; Passantino S; Zocchi C; Tassetti L; Gabriele M; Maurizi N; Marchionni N; Coppini R; Olivotto I
    Int J Cardiol; 2023 Jan; 370():271-278. PubMed ID: 36228766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice.
    Divchev D; Stöckl G;
    Cardiol Ther; 2017 Dec; 6(2):239-249. PubMed ID: 29116618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
    Storey KM; Wang J; Garberich RF; Bennett NM; Traverse JH; Arndt TL; Schmidt CW; Henry TD
    Am J Cardiol; 2020 Aug; 129():1-4. PubMed ID: 32540170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U;
    Cardiology; 2016; 133(2):83-90. PubMed ID: 26501486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine for Symptomatic Management of Microvascular Angina.
    Rayner-Hartley E; Parvand M; Humphries KH; Starovoytov A; Park JE; Sedlak T
    Am J Ther; 2020; 27(2):e151-e158. PubMed ID: 29746286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina].
    Kanorskii SG; Smolenskaya NV
    Ter Arkh; 2016; 88(12):33-40. PubMed ID: 28139557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
    Kohn CG; Parker MW; Limone BL; Coleman CI
    Am J Cardiol; 2014 Apr; 113(8):1306-11. PubMed ID: 24560062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study.
    Khot AM; Anuradha HV; Prakash VS; Shivamurathy MC
    J Pharmacol Pharmacother; 2017; 8(1):21-27. PubMed ID: 28405132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.
    Zarifis J; Grammatikou V; Kallistratos M; Katsivas A;
    Clin Cardiol; 2015 Dec; 38(12):725-32. PubMed ID: 26782939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.